| Nov 6 |
Regenxbio GAAP EPS of -$1.17 misses by $0.06, revenue of $24.2M misses by $0.2M
|
| Nov 6 |
Regenxbio (RGNX) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 6 |
Regenxbio: Q3 Earnings Snapshot
|
| Nov 6 |
REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational Updates
|
| Nov 5 |
Regenxbio Q3 2024 Earnings Preview
|
| Nov 4 |
REGENXBIO to Participate in Upcoming Investor Conferences
|
| Oct 18 |
REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
|
| Oct 17 |
JPMorgan Chase & Co. Reduces Stake in Regenxbio Inc
|
| Sep 17 |
REGENXBIO names Mitchell Chan as finance chief
|
| Sep 17 |
REGENXBIO Appoints Mitchell Chan as Chief Financial Officer
|
